Geode Capital Management
MAIA icon

Geode Capital Management’s MAIA Biotechnology MAIA Stock Holding History

Geode Capital Management’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$727K Buy
504,380
+143,899
+40% +$191K ﹤0.01% 3466
2026
Q1 		$505K Buy
360,481
+63,741
+21% +$118K ﹤0.01% 3582
2025
Q4 		$454K Buy
296,740
+25,684
+9% +$33.5K ﹤0.01% 3616
2025
Q3 		$418K Buy
271,056
+48,873
+22% +$79.8K ﹤0.01% 3686
2025
Q2 		$400K Buy
222,183
+7,746
+4% +$13.9K ﹤0.01% 3627
2025
Q1 		$328K Buy
214,437
+16,913
+9% +$31.3K ﹤0.01% 3690
2024
Q4 		$391K Buy
197,524
+4,961
+3% +$11.9K ﹤0.01% 3685
2024
Q3 		$541K Buy
192,563
+35,821
+23% +$112K ﹤0.01% 3559
2024
Q2 		$536K Buy
156,742
+103,485
+194% +$326K ﹤0.01% 3547
2024
Q1 		$117K Buy
53,257
+8,700
+20% +$13.1K ﹤0.01% 4113
2023
Q4 		$52.2K Hold
44,557
– – ﹤0.01% 4340
2023
Q3 		$98.1K Buy
44,557
+10,570
+31% +$20.9K ﹤0.01% 4260
2023
Q2 		$74.8K Buy
+33,987
New +$90.9K ﹤0.01% 4420

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Geode Capital Management's MAIA Position: Q2 2026 in Review

Geode Capital Management increased its MAIA Biotechnology (MAIA) stake by 40% in Q2 2026, buying an estimated $191K and bringing the position to 504,380 shares worth $727K. The position accounts for ﹤0.01% of the portfolio, ranked #3466.

Geode Capital Management first reported a position in MAIA in Q2 2023 and has held it in 13 quarters since. 36 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Geode Capital Management held 504,380 shares of MAIA Biotechnology worth $727K as of Q2 2026.
  • Geode Capital Management bought 143,899 MAIA Biotechnology shares in Q2 2026, an estimated $191K.
  • MAIA Biotechnology made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3466 holding.
  • Geode Capital Management first reported a position in MAIA Biotechnology in Q2 2023 and has held it in 13 quarters since.
  • 36 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.